Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zapatero, Almudenaa; * | Morente, Manuelb | de Vidales, Carmen Martína | Adrados, Magdalenac | Lopez, Consueloc | Nieto, Santiagod | González, María Jesús Artigab | Arellano, Ramóne | Conde, Alfonso Cruza | Vicente, Feliciano Garciaa
Affiliations: [a] Department of Radiation Oncology, La Princesa University Hospital, Madrid, Spain | [b] Spanish National Cancer Research Centre (CNIO), Madrid, Spain | [c] Department of Pathology, La Princesa University Hospital, Madrid, Spain | [d] Department of Pathology University Hospital Henares, Madrid, Spain | [e] Department of Urology, La Princesa University Hospital, Madrid, Spain
Correspondence: [*] Corresponding author: Almudena Zapatero, Radiation Oncology Department, Hospital Universitario de la Princesa. Diego de León 62, 28006 Madrid, Spain. Tel.: +34 915202315; Fax: +34 914013582; E-mail: almudena.zapatero@salud.madrid.org.
Abstract: Purpose:To analyze the expression of hypoxia inducible factor 1 alpha (HIF1A) and its correlation with clinical outcome in men with localized prostate cancer (PC) treated with dose escalation radiotherapy (RT) and androgen deprivation (AD). Methods:Between 1996 and 2004, 129 PC patients who had diagnostic biopsies pre-treatment and 24–36 months following RT were enrolled in this study. Median follow-up was 129 months. Suitable archival diagnostic tissue was obtained from 86 patients. Correlation analysis was done to assess association between HIF1A expression and clinical outcome. Results:HIF1A expression was observed in 25/86 (29%) of diagnostic biopsies, and in 5/14 (36%) of post-RT biopsies. No significant association was noted between HIF1A expression and clinical and treatment parameters. We also failed to show a significant correlation between HIF1A overexpression and outcome. A borderline significant relationship was observed between expression of HIF1A and overall survival (OS) (HR 0.03, p=0.08). Conclusion:To our knowledge this is the first study assessing the pattern of change of HIF1A staining in biopsies of patients prior and following treatment. While we did not find significant variations in the expression of HIF1A following radio-hormone therapy, a high HIF1A expression was unexpectedly associated with a borderline improved OS.
Keywords: Prostate cancer, radiotherapy, androgen deprivation, molecular markers, HIF1A
DOI: 10.3233/CBM-140439
Journal: Cancer Biomarkers, vol. 15, no. 1, pp. 41-46, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl